GenoMed, Inc. Finalizes Letter of Intent to Acquire Genomic Medicine, LLC.Business Editors/Health & Medical Writers SARASOTA, Fla.--(BUSINESS WIRE)--Nov. 26, 2001 GenoMed, Inc. (Pink Sheets:GMED) today announced that it had finalized See finalization. a Letter of Intent to acquire Genomic Medicine genomic medicine Molecular medicine The application of molecular methods to clinical medicine; MM encompasses diagnostic methods–eg, Southern, Western, and Northern blot hybridizations, DNA signal amplification by PCR, and use of agents produced by , LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a St. Louis, Missouri based genomic biotechnology company. GenoMed officials indicated that an announcement specific to the finalization of the acquisition of Genomic Medicine, LLC was expected within ten (10) days. For additional information please visit http://www.genomedics.com and/or contact Craig Hall Craig Hall is a rugby league player currently playing for Hull FC in the Super League. Primarily a centre, he broke into the first team in 2007 after progressing through Hull's academy. @ 941.366.6677 or email at chall@floridafunds.com. All statements in this press release that are not historical are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected. GenoMed, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in GenoMed, Inc.'s expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion